Zevra Therapeutics to Report First Quarter 2023 Results on May 15, 2023

3 years ago

CELEBRATION, Fla., May 09, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company, formerly KemPharm, Inc.),…

Cronos Group Reports 2023 First Quarter Results

3 years ago

Industry-leading balance sheet with $836 million in cash and short-term investments Targeting positive cash flow in 2024 Net revenue in…

Anavex Life Sciences Reports Fiscal 2023 Second Quarter Financial Results

3 years ago

Newly available preliminary efficacy results of surrogate biomarkers from the ANAVEX®2-73-AD-004 study; allowing initiation of discussions with regulatory agencies for…

Neuronetics Reports Record First Quarter 2023 Financial and Operating Results

3 years ago

MALVERN, Pa., May 09, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “company” or Neuronetics”) a commercial stage medical technology…

Sensei Biotherapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights

3 years ago

- Investigational New Drug (IND) application for SNS-101 cleared by U.S. Food and Drug Administration (FDA) with first patient dose…

Vivos Therapeutics Announces Additional Strategic Initiatives Aimed at Accelerating Anticipated Timeline for Cash Flow Positive Operations

3 years ago

Moss Adams LLP also appointed as new independent registered public accounting firmLITTLETON, Colo., May 09, 2023 (GLOBE NEWSWIRE) -- Vivos…

Prominent New York Internist Collaborates with Castle Connolly Private Health Partners, LLC to Join a Concierge Medical Program that Offers a Personalized Approach to Patient Care

3 years ago

Dr. Claire Binsol Prominent New York Internist Collaborates with Castle Connolly Private Health Partners, LLC to Join a Concierge Medical…

Biora Therapeutics to Report First Quarter 2023 Financial Results and Provide Corporate Update

3 years ago

SAN DIEGO, May 08, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic…

ProMIS Neurosciences Announces FDA Clearance of Investigational New Drug (IND) Application for PMN310 in Alzheimer’s Disease

3 years ago

TORONTO, Ontario and CAMBRIDGE, Massachusetts, May 08, 2023 (GLOBE NEWSWIRE) -- In preclinical studies, PMN310 demonstrated the ability to selectively…

Be The Match Champions Raise Over $420,000 at 2023 New York Gala to Save More Lives Through Blood Stem Cell Transplants

3 years ago

NY Times Bestselling Author and Transplant Recipient Suleika Jaouad Honored with Inaugural INSPIRE Award and Amazon Web Services Awarded for…